Multiple Sclerosis Disease-Modifying Therapies in the COVID-19 Era

Ann Neurol. 2020 Dec;88(6):1062-1064. doi: 10.1002/ana.25907. Epub 2020 Sep 30.
No abstract available

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Clinical Decision-Making
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / immunology
  • Coronavirus Infections / prevention & control*
  • Delivery of Health Care
  • Humans
  • Immunologic Factors / therapeutic use*
  • Multiple Sclerosis / drug therapy*
  • Pandemics / prevention & control*
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / immunology
  • Pneumonia, Viral / prevention & control*
  • SARS-CoV-2

Substances

  • Immunologic Factors